1. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Issue 30 (9th July 2015) Authors: Zeng, Weiguang; Tan, Amabel C.L.; Horrocks, Kylie; Jackson, David C. Journal: Vaccine Issue: Volume 33:Issue 30(2015) Page Start: 3526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Issue 30 (9th July 2015) Authors: Zeng, Weiguang; Tan, Amabel C.L.; Horrocks, Kylie; Jackson, David C. Journal: Vaccine Issue: Volume 33:Issue 30(2015) Page Start: 3526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bioactivity in an Aggrecan 32‐mer Fragment Is Mediated via Toll‐like Receptor 2. Issue 5 (May 2015) Authors: Lees, Sophie; Golub, Suzanne B.; Last, Karena; Zeng, Weiguang; Jackson, David C.; Sutton, Philip; Fosang, Amanda J. Journal: Arthritis & rheumatology Issue: Volume 67:Issue 5(2015) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chemical Synthesis of Monomeric, Dimeric and Tetrameric Forms of the Ectodomain of Influenza Matrix 2 Protein. Issue 5 (21st January 2016) Authors: Zeng, Weiguang; Horrocks, Kylie J.; Tan, Amabel C. L.; Jackson, David C. Journal: European journal of organic chemistry Issue: Issue 5(2016) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population. Issue 3 (16th January 2020) Authors: Zeng, Weiguang; Horrocks, Kylie J.; Tan, Amabel C.L.; Wong, Chinn Yi; Chua, Brendon Y.; Jackson, David C. Journal: Vaccine Issue: Volume 38:Issue 3(2020) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responses. (August 2017) Authors: Sekiya, Toshiki; Yamagishi, Junya; Gray, John Henry V.; Whitney, Paul G.; Martinelli, Axel; Zeng, Weiguang; Wong, Chinn Yi; Sugimoto, Chihiro; Jackson, David C.; Chua, Brendon Y. Journal: Biomaterials Issue: Volume 137(2017) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The design and proof of concept for a CD8+ T cell‐based vaccine inducing cross‐subtype protection against influenza A virus. Issue 1 (13th November 2012) Authors: Tan, Amabel C L; Deliyannis, Georgia; Bharadwaj, Mandvi; Brown, Lorena E; Zeng, Weiguang; Jackson, David C Journal: Immunology and cell biology Issue: Volume 91:Issue 1(2013) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Toll-Like Receptor 2 agonist PEG-Pam2Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites. Issue 3 (December 2018) Authors: Ernest, Medard; Hunja, Carol; Arakura, Yuka; Haraga, Yohei; Abkallo, Hussein M.; Zeng, Weiguang; Jackson, David C.; Chua, Brendon; Culleton, Richard Journal: International journal for parasitology Issue: Volume 8:Issue 3(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗